Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 991-1000 of 2867 for cancer

Edit search filters
  1. A Phase 2 Study Of Atezolizumab (An Engineered Anti-PDL1 Antibody) As Monotherapy Or In Combination With Avastin (Bevacizumab) Compared To Sunitinib In Patients With Untreated Advanced Renal Cell Carcinoma [IMmotion150]

    Jacksonville, FL

  2. A Study To Evaluate UV1 Vaccination Plus Nivolumab And Ipilimumab In Treatment Of Melanoma

    Scottsdale/Phoenix, AZ

  3. A Study Of Intratumoral Injection Of Autologous Dendritic Cells After High-Dose Conformal External Beam Radiotherapy In Patients With Unresectable Liver Cancer

    Rochester, MN

  4. Study To Evaluate The Safety And Efficacy Of Magrolimab In Combination With Azacitidine Versus Physician's Choice Of Venetoclax In Combination With Azacitidine Or Intensive Chemotherapy In Previously Untreated Adults With TP53 Mutant Acute Myeloid Leukemia

    Jacksonville, FL, Rochester, MN

  5. Combination Study Of SV-BR-1-GM In Combination With INCMGA00012 And Retifanlimab

    Jacksonville, FL

  6. Low Dose Computed Tomography For Lung Cancer Screening

    Rochester, MN

  7. A Trial Of Enzastaurin Plus Temozolomide During And Following Radiation Therapy In Patients With Newly Diagnosed Glioblastoma With Or Without The Novel Genomic Biomarker, DGM1

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study Of AO-176 As Monotherapy Combinated With Bortezomib And Dexamethasone In Adults With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. An Open-label Study Using ASP-1929 Photoimmunotherapy In Combination With Anti-PD1 Therapy In EGFR Expressing Advanced Solid Tumors

    Rochester, MN

  10. Comprehensive Genetic Assessment, Risk And Education In A Mammography Pilot

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer